Article PDF
References
Sata M : Role of circulating vascular progenitors in angiogenesis, vascular healing, and pulmonary hypertension: lessons from animal models. Arterioscler Thromb Vasc Biol 2006; 26: 1008–1014.
Sata M, Saiura A, Kunisato A, et al: Hematopoietic stem cells differentiate into vascular cells that participate in the pathogenesis of atherosclerosis. Nat Med 2002; 8: 403–409.
Hill JM, Zalos G, Halcox JP, et al: Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 2003; 348: 593–600.
Dimmeler S, Aicher A, Vasa M, et al: HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase/Akt pathway. J Clin Invest 2001; 108: 391–397.
Strehlow K, Werner N, Berweiler J, et al: Estrogen increases bone marrow–derived endothelial progenitor cell production and diminishes neointima formation. Circulation 2003; 107: 3059–3065.
Laufs U, Werner N, Link A, et al: Physical training increases endothelial progenitor cells, inhibits neointima formation, and enhances angiogenesis. Circulation 2004; 109: 220–226.
Yao E-H, Fukuda N, Matsumoto T, et al: Losartan improves the impaired function of endothelial progenitor cells in hypertension via an antioxidant effect. Hypertens Res 2007; 30: 1119–1128.
Imanishi T, Hano T, Nishio I : Angiotensin II accelerates endothelial progenitor cell senescence through induction of oxidative stress. J Hypertens 2005; 23: 97–104.
Bahlmann FH, de Groot K, Mueller O, Hertel B, Haller H, Fliser D : Stimulation of endothelial progenitor cells: a new putative therapeutic effect of angiotensin II receptor antagonists. Hypertension 2005; 45: 526–529.
Paul M, Poyan Mehr A, Kreutz R : Physiology of local renin-angiotensin systems. Physiol Rev 2006; 86: 747–803.
Haznedaroglu IC, Ozturk MA : Towards the understanding of the local hematopoietic bone marrow renin-angiotensin system. Int J Biochem Cell Biol 2003; 35: 867–880.
Rodgers KE, Xiong S, Steer R, diZerega GS : Effect of angiotensin II on hematopoietic progenitor cell proliferation. Stem Cells 2000; 18: 287–294.
Sasaki K, Murohara T, Ikeda H, et al: Evidence for the importance of angiotensin II type 1 receptor in ischemia-induced angiogenesis. J Clin Invest 2002; 109: 603–611.
Egami K, Murohara T, Shimada T, et al: Role of host angiotensin II type 1 receptor in tumor angiogenesis and growth. J Clin Invest 2003; 112: 67–75.
Noble M, Smith J, Power J, Mayer-Proschel M : Redox state as a central modulator of precursor cell function. Ann N Y Acad Sci 2003; 991: 251–271.
Losordo DW, Schatz RA, White CJ, et al: Intramyocardial transplantation of autologous CD34+ stem cells for intractable angina: a phase I/IIa double-blind, randomized controlled trial. Circulation 2007; 115: 3165–3172.
Hristov M, Weber C : The therapeutic potential of progenitor cells in ischemic heart disease—past, present and future. Basic Res Cardiol 2006; 101: 1–7.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Fukuda, D., Sata, M. The Renin-Angiotensin System: A Potential Modulator of Endothelial Progenitor Cells. Hypertens Res 30, 1017–1018 (2007). https://doi.org/10.1291/hypres.30.1017
Received:
Issue Date:
DOI: https://doi.org/10.1291/hypres.30.1017
Keywords
This article is cited by
-
Rosuvastatin for Reduction of Myocardial Damage during Coronary Angioplasty - the Remedy Trial
Cardiovascular Drugs and Therapy (2016)